Work

Abstract 1082: MerTK promotes resistance to irreversible EGFR TKIs by activation of the PI3K-AKT pathway in NSCLCs expressing wild-type EGFR

Year: 2017

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2017-1082

Authors: Dan Yan, Xiaodong Wang, Stephen V. Frye, Shelton H. Earp, Deborah DeRyckere, Douglas K. Graham

Institutions: Aflac (United States), University of North Carolina at Chapel Hill

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2740846367

Cites:

Cited by: 2

Related to: 10